Insulin and cortisol have opposing effects on glucose metabolism in peripheral tissue and in brain. Insulin increases the rate of glucose utilization, whereas cortisol reduces insulin-mediated glucose disposal. Furthermore, defects in responsivity to insulin and cortisol increase with aging and many contribute to the pathophysiology of Alzheimer's disease (AD). In particular, previous work has established a link between insulin resistance and apolipoprotein E (apoE) genotype. Despite the close relationship between insulin and cortisol action and their putative role in AD, no study has examined the interactive effects of these systems on memory in normal adults or in patients with AD. The propose studies will use both clinical and molecular memory in normal adults or in patients with AD. The proposed studies will use both clinical and molecular biological methods to address the question of whether insulin-cortisol interactions differ for patients of varying apoE genotypes with AD and with Mild Cognitive Impairment (MCI). A clinical study will be conducted to test the hypotheses that raising cortisol levels during insulin infusion will attenuate the typical memory-enhancing effect of insulin, whereas suppressing endogenous cortisol during insulin infusion will increase the typical memory-enhancing effect of insulin for normal adults and for patients with AD or MCI. The proposed studies will also examine potential mechanisms through which cortisol affects insulin signaling by examining the effect of chronic glucocorticoid elevations on insulin degrading enzyme (IDE) expression and activity, and on insulin receptor distributions in non-human primate brain. Furthermore, preliminary work suggests that IDE expression is reduced in AD brain tissue, and that the nature of this abnormality may differ according to apoE genotype. In the final specific aim, we will expand this work to examine in detail regional IDE expression and activity in normal and AD brain from patients of differing apoE genotypes.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG005136-17
Application #
6345524
Study Section
Special Emphasis Panel (ZAG1-BJS-3 (J3))
Project Start
1985-09-30
Project End
2005-04-30
Budget Start
Budget End
Support Year
17
Fiscal Year
2000
Total Cost
$209,534
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Nafikov, Rafael A; Nato Jr, Alejandro Q; Sohi, Harkirat et al. (2018) Analysis of pedigree data in populations with multiple ancestries: Strategies for dealing with admixture in Caribbean Hispanic families from the ADSP. Genet Epidemiol 42:500-515
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Young, Jessica E; Fong, Lauren K; Frankowski, Harald et al. (2018) Stabilizing the Retromer Complex in a Human Stem Cell Model of Alzheimer's Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein. Stem Cell Reports 10:1046-1058
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Wang, Lucy Y; Raskind, Murray A; Wilkinson, Charles W et al. (2018) Associations between CSF cortisol and CSF norepinephrine in cognitively normal controls and patients with amnestic MCI and AD dementia. Int J Geriatr Psychiatry 33:763-768
Moreno, Monica A; Or-Geva, Noga; Aftab, Blake T et al. (2018) Molecular signature of Epstein-Barr virus infection in MS brain lesions. Neurol Neuroimmunol Neuroinflamm 5:e466

Showing the most recent 10 out of 753 publications